CORC

浏览/检索结果: 共127条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study 期刊论文
GENES CHROMOSOMES & CANCER, 2022
作者:  Wang, Wenxian;  Gu, Xiaodong;  Si, Jinfei;  Pu, Xingxiang;  Wang, Liping
收藏  |  浏览/下载:31/0  |  提交时间:2022/05/16
Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements 期刊论文
NPJ PRECISION ONCOLOGY, 2022, 卷号: 6
作者:  Zhang, Yongchang;  Huang, Zhe;  Zeng, Liang;  Zhang, Xiangyu;  Li, Yizhi
收藏  |  浏览/下载:20/0  |  提交时间:2022/05/05
Noncanonical Gene Fusions Detected at the DNA Level Necessitate Orthogonal Diagnosis Methods Before Targeted Therapy 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2021, 卷号: 16
作者:  Song, Zhengbo;  Lu, Chenyu;  Xu, Chun-Wei;  Zheng, Zongli
收藏  |  浏览/下载:14/0  |  提交时间:2021/05/17
Quality of Life and Subgroup Analysis in a Phase 3 Randomized Study of Ensartinib vs Crizotinib in ALK-Positive NSCLC Patients: eXalt3. 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2021, 卷号: 16
作者:  Selvaggi, G.;  Wu, Y.;  Wang, Z.;  Wu, G.;  Poddubskaya, E.
收藏  |  浏览/下载:45/0  |  提交时间:2021/05/17
ALK  NSCLC  ensartinib  
Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 10
作者:  Cai, Lei;  Wang, Jiangfeng;  Yan, Junrong;  Zeng, Jian;  Zhu, Liang
收藏  |  浏览/下载:39/0  |  提交时间:2021/03/15
Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 10
作者:  Cai, Lei;  Wang, Jiangfeng;  Yan, Junrong;  Zeng, Jian;  Zhu, Liang
收藏  |  浏览/下载:29/0  |  提交时间:2021/03/15
A Case of Resistance to Selective RET-TKI Therapy With Pleural-Genotyped MET Amplification and Response to Crizotinib 期刊论文
CLINICAL LUNG CANCER, 2021, 卷号: 22
作者:  Chen, Kaiyan;  Zhang, Fanrong;  Pan, Guoqiang;  Sheng, Jiamin;  Ye, Junyi
收藏  |  浏览/下载:26/0  |  提交时间:2021/03/15
Phase III Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK) POSITIVE NSCLC Patients: eXalt3 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15
作者:  Selvaggi, G.;  Wakelee, H. A.;  Mok, T.;  Wu, Y. -L.;  Reck, M.
收藏  |  浏览/下载:28/0  |  提交时间:2020/11/30
SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors 期刊论文
ACTA PHARMACOLOGICA SINICA, 2020, 页码: 7
作者:  Xia, Zong-jun;  Ji, Yin-chun;  Sun, De-qiao;  Peng, Xia;  Gao, Ying-lei
收藏  |  浏览/下载:75/0  |  提交时间:2020/12/21
The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patients 期刊论文
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020
作者:  Song, Zhengbo;  Liu, Tianchi;  Shi, Lei;  Yu, Zongyang;  Shen, Qing
收藏  |  浏览/下载:18/0  |  提交时间:2020/10/26


©版权所有 ©2017 CSpace - Powered by CSpace